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Abstract: It has been demonstrated that 5-HT1A receptors play an important role in the pathophysiology of schizophrenia. 
Because Gastrodia elata Bl (GE) modulates the serotonergic system, we examined whether GE could affect phencyclidine 
(PCP)-induced abnormal behavior in mice. Repeated treatment with PCP increased immobility time, while it decreased 
social interaction time and recognition memory. PCP-induced abnormal behaviors were significantly attenuated by GE, 
and these effects were comparable to those of 8-OH-DPAT, a 5-HT1A receptor agonist. Furthermore, GE-mediated effects 
were counteracted by WAY 100635, a 5-HT1A receptor antagonist. Our results suggest that the antipsychotic effects of GE 
are, at least in part, mediated via activation of 5-HT1A in mice. 
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INTRODUCTION 
  Schizophrenia is a chronic, devastating, and costly men-
tal illness, affecting about 1% of the world population. It 
develops progressively, and is often undetected during child-
hood and adolescence in a premorbid phase, leading to the 
onset of psychosis in early adulthood [1]. 
  Phencyclidine [1-(1-phenylcyclohexyl)piperidine hydro-
chloride (PCP)], a non-competitive N-methyl-D-aspartate 
(NMDA) antagonist, has been shown to induce schizophrenia-
like psychosis, with positive symptoms, negative symptoms, 
and cognitive deficits in humans [2], which persist for   
several weeks after withdrawal from chronic PCP use [3].  
  To understand the pathophysiology of schizophrenia, an 
animal model of schizophrenia was established using PCP 
[3]. Nabeshima and colleagues previously demonstrated that 
repeated treatment with PCP induces  several behavioral   
abnormalities, such as increased immobility in a forced 
swimming test, social deficits on a social interaction test, 
impairment of latent learning in a water finding test, and 
associative learning impairment in cue and contextual fear 
conditional tests in mice [3]. Thus, PCP-treated mice might 
be a useful animal model of schizophrenia. 
  Several lines of evidence have suggested that serotonin 5-
HT1A receptors may play a role in the pathophysiology of  
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psychiatric diseases, including schizophrenia, and that 5-
HT1A receptors might be an important target for emotion and 
cognition [4]. 
 Gastrodia  elata Blume (GE) is a well-known herbal 
agent that has long been used to treat headache, paralysis, 
migraine, and other neurological disorders in traditional   
oriental  medicine. Major components of GE include   
gastrodin, p-hydroxybenzyl aldehyde, p-hydroxybenzyl 
alcohol, vanillyl alcohol, and vanillin. Earlier reports indi-
cated that GE has various biological properties, including 
anti-convulsant, anti-oxidant, cognitive enhancing, anx-
iolytic, and anti-depressant effects [5]. Recently, it was dem-
onstrated that GE significantly decreased immobility dura-
tion in a forced-swimming test in rats, primarily by modulat-
ing the serotonergic system [6].  
  Thus, to extend the pharmacological investigation of GE, 
we examined whether GE affected PCP-induced changes in 
immobility, social interaction, and cognitive function in mice. 
We also examined whether the 5-HT1A receptor is involved in 
GE-mediated pharmacological actions in response to PCP. 
METHODS 
  All animals were treated in accordance with the NIH 
Guide for the care and use of laboratory animals (NIH Pub-
lication No. 85-23, 1985; www.dels.nas.edu/ila). This study 
was performed in accordance with the Institute for Labora-
tory Animal Research (ILAR) guidelines for the care and use 
of laboratory animals.  
  Male C57BL/6J mice or male ICR mice (Bio Genomic 
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Do, South Korea), weighing 25±3 g, were maintained on a 
12:12 h light:dark cycle and fed ad libitum. Male ICR mice 
were only used as the “target” in the social interaction test, 
with no drug treatment.  
 N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-(2-
pyridinyl)cyclohexane carboxamide trihydrochloride (WAY 
100635; Sigma-Aldrich, St. Louis, MO, USA), PCP hydro-
chloride (Tocris Bioscience, Ellisville, MO, USA), and (+)-
8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT; Sigma-
Aldrich) were dissolved in 0.9% sterile saline. The GE was 
obtained from Samsung Herb Medicine, Co. (Chunchon, 
South Korea) and was suspended in 0.5% carboxymethylcel-
lulose. All solutions were prepared immediately before use. 
Experimental schedules are shown in Fig. (1).  
  The novel object recognition, forced swimming, and so-
cial interaction tests were performed as described previously 
[6,7,8]. An automated video-tracking system (Noldus Infor-
mation Technology, Wageningen, The Netherlands) was 
used to record and analyze the movements of mice in all 
three tests. 
  Statistical analyses were performed using one-way analy-
sis of variance (ANOVA) or repeated measure one-way 
ANOVA. A post-hoc Fisher’s PLSD test was then applied. A 
P value < 0.05 was deemed to indicate statistical significance. 
RESULTS AND DISCUSSION 
  Repeated treatment with PCP resulted in significant   
increases (P < 0.01) in immobility time in the forced swim-
ming test (Fig. 2A), while PCP resulted in significant   
decreases (P < 0.01) in the interaction time in the social   
interaction test (Fig. 2B) and exploration rate for a novel 
object (P < 0.01) in the novel object recognition test (Fig. 2C). 
GE treatment significantly attenuated PCP-induced increase 
in immobility time [GE (500 mg/kg) + PCP vs. saline + PCP, 
P < 0.05; GE (1000 mg/kg) + PCP vs. saline + PCP, P < 0.01] 
(Fig. 2A), sociability deficit [GE (1000 mg/kg) + PCP vs. 
saline + PCP, P < 0.01] (Fig. 2B), and impaired visual rec-
ognition memory [GE (1000 mg/kg) + PCP vs. saline + PCP, 
P < 0.01] (Fig. 2C), in a dose-dependent manner. The effects 
of GE (8-OH-DPAT + PCP vs. saline + PCP, P < 0.05 in all 
behaviors) were comparable to those of 8-OH-DPAT (0.05 
mg/kg, i.p.), a 5-HT1A receptor agonist. Consistently, WAY 
100635 (0.5 mg/kg, i.p.), a 5-HT1A receptor antagonist, sig-
nificantly inhibited GE-mediated pharmacological actions 
[forced swimming test: WAY 100635 + GE (1000 mg/kg) + 
PCP vs. saline + GE (1000 mg/kg) + PCP, P < 0.05; social 
interaction test and novel object recognition test: WAY 
100635 + GE (1000 mg/kg) + PCP vs. saline + GE (1000 
mg/kg) + PCP, P < 0.01] in response to PCP (Fig. 2). These 
results suggest that GE attenuated PCP-induced changes in 
immobility time, social interaction, and cognitive function 
via modulation of 5-HT1A receptors. 
  Our results are consistent with earlier findings that re-
peated treatment with PCP showed significant increases in 
immobility time and significant decreases in social interac-
tion and recognition memory in mice [3]. Prolonged expo-
sure to GE significantly blocked PCP-induced behavioral 
effects, in a dose-related manner. The protective effects of 
GE in response to PCP were about equipotent to those of the 
5-HT1A receptor agonist 8-OH-DPAT (0.05  mg/kg, i.p.). 
Furthermore, the 5-HT1A receptor antagonist WAY 100635 
(WAY; 0.5  mg/kg, i.p.) significantly counteracted GE-
mediated pharmacological effects in response to PCP. Thus, 
we believe that GE-mediated activation of 5-HT1A receptors 
may be important in antipsychotic effects in response to 
PCP, although this remains to be explored further in other 
GE-mediated neuropharmacological activities. 
 
 
 
 
 
 
 
 
 
Fig. (1). Experimental schedules. PCP = phencyclidine, GE = Gastrodia elata Blume, 8OH = 8-OH-DPAT, WAY = WAY 100635. 8-OH-
DPAT was used as a reference drug. Mice were treated with PCP (10 mg/kg/day, s.c.) for 14 consecutive days. After a 7- or 8-day with-
drawal period, the novel object recognition, forced swimming, and social interaction tests were performed using independent sets of mice; 
each set of mice was used for one of the three behavioral tests. Treatment with GE (500 or 1000  mg/kg/day, p.o.) or 8-OH-DPAT 
(0.05  mg/kg/day, i.p.) was started from 4  days before the first PCP injection, and continued throughout the experimental period. 
WAY 100635 (0.5 mg/kg/day, i.p.) was administered during the PCP withdrawal period. GE was injected 1 h prior to PCP or WAY 100635, 
and WAY 100635 was injected 30 min prior to the behavior test. 
GE (500 or 1000 mg/kg/day, p.o. x 26) or
8OH (0.05 mg/kg/day, i.p. x 26)
PCP 
(10 mg/kg/day, s.c. x 14)
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(0.5 mg/kg/day, i.p. x 7)
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Fig. (2). Effect of WAY  100635 (WAY) on the GE-mediated 
pharmacological actions in response to PCP-induced changes in the 
immobility time (A), social interaction time (B), and recognition 
memory (C). Sal = saline, GE (500) = GE 500 mg/kg, p.o., GE 
(1000) = GE 1000 mg/kg, p.o., 8OH = 8-OH-DPAT 0.5 mg/kg. i.p., 
WAY = WAY 100635 0.5 mg/kg, i.p. Each value is the mean ± 
S.E.M. of 12 mice. 
* P < 0.01 vs. Saline + Saline + Saline, 
# P < 
0.05, 
## P < 0.01 vs. Saline + Saline + PCP, 
& P < 0.05, 
&& P < 0.01 
vs. Saline + GE (1000) + PCP (One-way ANOVA followed by 
Fisher’s PLSD test). 
  Recent finding have suggested that repeated PCP treat-
ment significantly decreases the density of 5-HT1A receptors 
in the mouse brain [9]. 5-HT1A agonist properties are thought 
to improve negative symptoms and cognitive deficits by 
stimulating the release of dopamine in the prefrontal cortex 
[10]. Consistent with this, Sumiyoshi et al. [11] reported that 
the 5-HT1A agonists exert anti-depressant-like effects [12], of 
particular interest for schizophrenic patients suffering from 
depression. Recent reports have indicated that potential an-
tipsychotic effects on PCP require combined modulation of 
5-HT1A and dopamine receptors [8]. Interestingly, the GE-
mediated anti-depressant effects are exerted, at least in part, 
by dopaminergic modulation in the rat brain [6]; however, 
the interaction between 5-HT1A and specific dopamine recep-
tors remains to be determined. 
  Similar to GE, various 5HT1A receptor agonists, such as 
buspirone, 8-OH-DPAT, and ipsapirione, have been shown 
to enhance social interaction [13]. Furthermore, various pre-
clinical data strengthen the notion that targeting the 5HT1A 
receptor system should result in beneficial effects on dys-
functional social behavior, possibly not only in schizo-
phrenic patients but also in the population suffering from 
social withdrawal of other etiologies. 
 Hagiwara  et al. [9] demonstrated that the hippocampal 
density of 5-HT1A receptor is much higher than the frontal 
cortical density of 5-HT receptor in mice, and that repeated 
treatment with PCP did not significantly alter the frontal 
cortical density of 5-HT, but did change the hippocampal 
density of 5-HT receptors, and that perospirone, a 5-HT1A 
receptor agonist, ameliorated PCP-induced cognitive deficits, 
as measured by a novel object recognition test. Thus, the 
cognitive enhancing effect of GE or 8-OH-DPAT may be 
similar to that of perospirone. It remains to be determined 
whether GE also modulates hippocampal 5-HT1A receptors 
in our experimental system. 
  Atypical antipsychotic drugs, such as clozapine, ziprai-
done, aripiprazole, and quetiapine, are all 5-HT1A receptor 
(partial) agonists, which may be relevant for their actions in 
treating schizophrenia [14]. While current antipsychotic 
treatments are effective against positive symptoms, they 
have significant side effects and have little effect on negative 
or cognitive symptoms [15]. 
  In conclusion, our finding suggests that 5-HT1A receptor 
agonistic properties of GE offer potential therapeutic advan-
tages in response to PCP-induced schizophrenia-like psycho-
sis, although many details of the GE-mediated effect(s) re-
main to be determined. 
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